<i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts

Tetherin, an interferon-induced host protein encoded by the bone marrow stromal antigen 2 (BST2/CD317/HM1.24) gene, is involved in obstructing the release of many retroviruses and other enveloped viruses by cross-linking the budding virus particles to the cell surface. This activity is antagonized i...

Full description

Bibliographic Details
Main Authors: Patil Sneha, Urmi Shah, Seetharaman Balaji
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:Medical Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3271/7/6/74
id doaj-68df01ff224044c3bf879c82c86f53bd
record_format Article
spelling doaj-68df01ff224044c3bf879c82c86f53bd2020-11-25T00:16:48ZengMDPI AGMedical Sciences2076-32712019-06-01767410.3390/medsci7060074medsci7060074<i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational CounterpartsPatil Sneha0Urmi Shah1Seetharaman Balaji2School of Biotechnology and Bioinformatics, D Y Patil Deemed to be University, Plot 50, Sector 15, CBD Belapur, Navi Mumbai, Maharashtra 400614, IndiaSchool of Biotechnology and Bioinformatics, D Y Patil Deemed to be University, Plot 50, Sector 15, CBD Belapur, Navi Mumbai, Maharashtra 400614, IndiaDepartment of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, Karnataka 576104, IndiaTetherin, an interferon-induced host protein encoded by the bone marrow stromal antigen 2 (BST2/CD317/HM1.24) gene, is involved in obstructing the release of many retroviruses and other enveloped viruses by cross-linking the budding virus particles to the cell surface. This activity is antagonized in the case of human immunodeficiency virus (HIV)-1 wherein its accessory protein Viral Protein U (Vpu) interacts with tetherin, causing its downregulation from the cell surface. Vpu and tetherin connect through their transmembrane (TM) domains, culminating into events leading to tetherin degradation by recruitment of β-TrCP2. However, mutations in the TM domains of both proteins are reported to act as a resistance mechanism to Vpu countermeasure impacting tetherin’s sensitivity towards Vpu but retaining its antiviral activity. Our study illustrates the binding aspects of blood-derived, brain-derived, and consensus HIV-1 Vpu with tetherin through protein–protein docking. The analysis of the bound complexes confirms the blood-derived Vpu–tetherin complex to have the best binding affinity as compared to other two. The mutations in tetherin and Vpu are devised computationally and are subjected to protein–protein interactions. The complexes are tested for their binding affinities, residue connections, hydrophobic forces, and, finally, the effect of mutation on their interactions. The single point mutations in tetherin at positions L23Y, L24T, and P40T, and triple mutations at {L22S, F44Y, L37I} and {L23T, L37T, T45I}, while single point mutations in Vpu at positions A19H and W23Y and triplet of mutations at {V10K, A11L, A19T}, {V14T, I18T, I26S}, and {A11T, V14L, A15T} have revealed no polar contacts with minimal hydrophobic interactions between Vpu and tetherin, resulting in reduced binding affinity. Additionally, we have explored the aggregation potential of tetherin and its association with the brain-derived Vpu protein. This work is a possible step toward an understanding of Vpu–tetherin interactions.https://www.mdpi.com/2076-3271/7/6/74HIV-1 Vputetherintransmembrane interactionsaggregation potential
collection DOAJ
language English
format Article
sources DOAJ
author Patil Sneha
Urmi Shah
Seetharaman Balaji
spellingShingle Patil Sneha
Urmi Shah
Seetharaman Balaji
<i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts
Medical Sciences
HIV-1 Vpu
tetherin
transmembrane interactions
aggregation potential
author_facet Patil Sneha
Urmi Shah
Seetharaman Balaji
author_sort Patil Sneha
title <i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts
title_short <i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts
title_full <i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts
title_fullStr <i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts
title_full_unstemmed <i>In Silico</i> Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts
title_sort <i>in silico</i> insights into hiv-1 vpu-tetherin interactions and its mutational counterparts
publisher MDPI AG
series Medical Sciences
issn 2076-3271
publishDate 2019-06-01
description Tetherin, an interferon-induced host protein encoded by the bone marrow stromal antigen 2 (BST2/CD317/HM1.24) gene, is involved in obstructing the release of many retroviruses and other enveloped viruses by cross-linking the budding virus particles to the cell surface. This activity is antagonized in the case of human immunodeficiency virus (HIV)-1 wherein its accessory protein Viral Protein U (Vpu) interacts with tetherin, causing its downregulation from the cell surface. Vpu and tetherin connect through their transmembrane (TM) domains, culminating into events leading to tetherin degradation by recruitment of β-TrCP2. However, mutations in the TM domains of both proteins are reported to act as a resistance mechanism to Vpu countermeasure impacting tetherin’s sensitivity towards Vpu but retaining its antiviral activity. Our study illustrates the binding aspects of blood-derived, brain-derived, and consensus HIV-1 Vpu with tetherin through protein–protein docking. The analysis of the bound complexes confirms the blood-derived Vpu–tetherin complex to have the best binding affinity as compared to other two. The mutations in tetherin and Vpu are devised computationally and are subjected to protein–protein interactions. The complexes are tested for their binding affinities, residue connections, hydrophobic forces, and, finally, the effect of mutation on their interactions. The single point mutations in tetherin at positions L23Y, L24T, and P40T, and triple mutations at {L22S, F44Y, L37I} and {L23T, L37T, T45I}, while single point mutations in Vpu at positions A19H and W23Y and triplet of mutations at {V10K, A11L, A19T}, {V14T, I18T, I26S}, and {A11T, V14L, A15T} have revealed no polar contacts with minimal hydrophobic interactions between Vpu and tetherin, resulting in reduced binding affinity. Additionally, we have explored the aggregation potential of tetherin and its association with the brain-derived Vpu protein. This work is a possible step toward an understanding of Vpu–tetherin interactions.
topic HIV-1 Vpu
tetherin
transmembrane interactions
aggregation potential
url https://www.mdpi.com/2076-3271/7/6/74
work_keys_str_mv AT patilsneha iinsilicoiinsightsintohiv1vputetherininteractionsanditsmutationalcounterparts
AT urmishah iinsilicoiinsightsintohiv1vputetherininteractionsanditsmutationalcounterparts
AT seetharamanbalaji iinsilicoiinsightsintohiv1vputetherininteractionsanditsmutationalcounterparts
_version_ 1725382598322028544